Your Portable Rapid Test Reader
In recent years, the field of diagnostic medicine has witnessed groundbreaking advancements with the introduction of pocket lateral flow readers. These compact, handheld devices have revolutionized point-of-care testing, offering rapid and accurate results for a wide range of medical conditions. This technological marvel combines the principles of lateral flow assays with cutting-edge optical sensing, enabling healthcare professionals to make informed decisions swiftly and efficiently. The field of home diagnostics is no longer just a theoretical concept; we see home diagnostics as a significant opportunity to improve the health and lifestyle of every individual and even entire societies. Home testing or self-testing offers completely new possibilities and approaches for disease diagnosis and chronic disease monitoring. Furthermore, it opens opportunities to lead a healthy lifestyle by simply testing blood values or other parameters at home. Home diagnostics represents a disruptive innovation that will benefit not only patients and users but also test manufacturers.
At the heart of a pocket lateral flow reader lies its sophisticated optical system. This system illuminates the test strip, which contains specific capture molecules for the target analyte, with a carefully calibrated light source. The interaction between the target analyte and the capture molecules leads to the formation of a distinctive complex. This complex, upon migrating along the strip, encounters a detection zone where a secondary set of molecules generates a signal. This signal is then captured by the reader's photodetector or camera and transformed into a quantifiable output.
One of the remarkable strengths of the ESEQuant Go is its ability to perform multiplexed assays. This means that a single test strip can simultaneously detect multiple analytes, providing a comprehensive diagnostic profile. This capability is invaluable in scenarios where a holistic view of a patient's health is required, such as in the management of chronic diseases or during infectious outbreaks. Unlike traditional lateral flow tests, which yield qualitative results (positive or negative), our lateral flow readers have the capability to provide quantitative measurements. This feature is particularly critical in situations where precise quantification of analyte concentration is essential for clinical decision-making.
One of the key features is the capability to read both visually labeled rapid tests (mainly colloidal gold particles) and fluorescent labeled tests with Europium. Europium is a widely used fluorescent marker in immunoassays. It is characterized by its long fluorescence lifetime, which makes it possible to minimize disturbing background signals. This is crucial for the sensitivity and accuracy of tests, especially in clinical diagnostics.
DIALUNOX is offering this new reader unit to companies aiming for cost-efficient precision diagnostics for their rapid test portfolio. Our customers can rely on over 15 years of experience in digital rapid test interpretation. Our network of partners also allows for the development of tests, including integration into a reader system.
Don't hesitate to contact us if you are searching for a cost-effective, highly user-friendly reader solution with outstanding quality.
Learn more about our rapid test devices on our product page at www.lateralflowreader.com or visit our MEDICA booth 3C96 from November 13 to 16, 2023, in Düsseldorf